Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc. (BCLI) — Form 8-K: Current report
About this filing
Brainstorm Cell Therapeutics Inc. (BCLI) filed an 8-K on Nov 16, 2026 reporting results of operations (earnings) (Item 2.02), with exhibits (Item 9.01).
Key facts
- Item 2.02 · Results of operations (earnings)
- Item 9.01 · Financial statements and exhibits
More BCLI filings
- 10-Q
Filed Nov 16, 2026
- 10-Q
Filed Aug 14, 2026
- 8-K
Filed Aug 14, 2026
- 8-K
Filed Jul 30, 2026
- 4
Filed Jul 28, 2026
- 4
Filed Jul 28, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.